NASDAQ Infectious Diseases Market News

Dr. Eugene Sun Appointed to Novan Board of Directors

Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEOWill provide ...

Dr. Eugene Sun Appointed to Novan Board of Directors

Complements existing Board expertise as 30-year clinician, drug developer and former biopharmaceutical CEOWill provide ...

Motif Bio to Present Iclaprim Data at ECCMID 2018

Phase 3 trial results for REVIVE-2 in patients with ABSSSIPotential cost savings opportunities with ...

Motif Bio to Present Iclaprim Data at ECCMID 2018

Phase 3 trial results for REVIVE-2 in patients with ABSSSIPotential cost savings opportunities with ...